A detailed history of Fundamentun, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fundamentun, LLC holds 80,481 shares of MRK stock, worth $8.04 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
80,481
Previous 55,119 46.01%
Holding current value
$8.04 Million
Previous $6.82 Million 33.94%
% of portfolio
0.68%
Previous 0.61%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$111.15 - $128.97 $2.82 Million - $3.27 Million
25,362 Added 46.01%
80,481 $9.14 Million
Q2 2024

Jul 24, 2024

BUY
$123.8 - $132.96 $2.1 Million - $2.26 Million
16,999 Added 44.59%
55,119 $6.82 Million
Q1 2024

Apr 16, 2024

BUY
$113.24 - $131.95 $2.17 Million - $2.52 Million
19,126 Added 100.69%
38,120 $5.03 Million
Q4 2023

Jan 24, 2024

BUY
$100.18 - $109.02 $4,708 - $5,123
47 Added 0.25%
18,994 $2.07 Million
Q3 2023

Oct 24, 2023

BUY
$102.95 - $114.33 $113,245 - $125,763
1,100 Added 6.16%
18,947 $1.95 Million
Q2 2023

Jul 18, 2023

BUY
$108.61 - $118.38 $202,883 - $221,133
1,868 Added 11.69%
17,847 $2.06 Million
Q1 2023

May 01, 2023

BUY
$102.94 - $114.86 $978,856 - $1.09 Million
9,509 Added 146.97%
15,979 $1.7 Million
Q4 2022

Jan 19, 2023

SELL
$87.44 - $112.11 $16,263 - $20,852
-186 Reduced 2.79%
6,470 $0
Q3 2022

Oct 24, 2022

BUY
$84.53 - $94.96 $248,433 - $279,087
2,939 Added 79.07%
6,656 $573,000
Q2 2022

Sep 06, 2022

BUY
$83.49 - $94.64 $18,618 - $21,104
223 Added 6.38%
3,717 $339,000
Q1 2022

Apr 26, 2022

BUY
$73.51 - $82.4 $14,040 - $15,738
191 Added 5.78%
3,494 $287,000
Q4 2021

Jan 14, 2022

SELL
$72.28 - $90.54 $346,727 - $434,320
-4,797 Reduced 59.22%
3,303 $253,000
Q3 2021

Oct 19, 2021

SELL
$71.68 - $78.83 $2.45 Million - $2.69 Million
-34,153 Reduced 80.83%
8,100 $608,000
Q2 2021

Jul 19, 2021

SELL
$70.31 - $77.77 $191,032 - $211,301
-2,717 Reduced 6.04%
42,253 $3.29 Million
Q1 2021

Apr 27, 2021

SELL
$68.86 - $81.11 $155,967 - $183,714
-2,265 Reduced 4.8%
44,970 $3.47 Million
Q4 2020

Jan 29, 2021

BUY
$71.77 - $79.65 $627,485 - $696,379
8,743 Added 22.71%
47,235 $3.86 Million
Q3 2020

Oct 29, 2020

BUY
$73.18 - $82.95 $376,877 - $427,192
5,150 Added 15.45%
38,492 $3.19 Million
Q2 2020

Jul 28, 2020

BUY
$70.42 - $80.13 $426,463 - $485,267
6,056 Added 22.19%
33,342 $2.58 Million
Q1 2020

May 04, 2020

BUY
$63.36 - $87.82 $755,694 - $1.05 Million
11,927 Added 77.65%
27,286 $2.1 Million
Q4 2019

Jan 29, 2020

BUY
$77.58 - $87.54 $83,088 - $93,755
1,071 Added 7.5%
15,359 $1.4 Million
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $105,751 - $115,272
1,390 Added 10.78%
14,288 $1.2 Million
Q2 2019

Aug 06, 2019

BUY
$69.84 - $81.59 $125,642 - $146,780
1,799 Added 16.21%
12,898 $1.08 Million
Q1 2019

May 07, 2019

BUY
$69.58 - $79.36 $772,268 - $880,816
11,099 New
11,099 $923,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Fundamentun, LLC Portfolio

Follow Fundamentun, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fundamentun, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fundamentun, LLC with notifications on news.